{"id":47263,"date":"2022-08-12T20:02:06","date_gmt":"2022-08-12T18:02:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/"},"modified":"2022-08-12T20:02:06","modified_gmt":"2022-08-12T18:02:06","slug":"pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/","title":{"rendered":"Pearl Named 2022 “Hot Vendor” in Computer Vision by Aragon Research"},"content":{"rendered":"
\n

\nVendors selected for the report are noteworthy, visionary, and innovative in their respective fields<\/i>\n<\/p>\n

LOS ANGELES–(BUSINESS WIRE)–Pearl<\/a>, the global leader in dental AI solutions, announced today that it has been included on the 2022 list of “Hot Vendors” in Computer Vision<\/a>i<\/sup> by Aragon Research, Inc. The firm\u2019s report identifies vendors whose technology provides transformative capabilities that revolutionize the way businesses interact with customers.\n<\/p>\n

<\/a><\/p>\n

\nPearl is leading the worldwide dental artificial intelligence (AI) revolution with a suite of computer vision solutions, including Second Opinion\u00ae<\/i><\/a> and Practice Intelligence\u00ae<\/a>, that aim to enhance the standard of patient care in dentistry. Second Opinion\u00ae<\/i> is the first and only FDA-cleared chairside AI software to help dentists detect numerous pathologies in x-rays of dental patients 12 and older. It identifies and highlights key pathologic and non-pathological findings, supporting dental professionals in their review of radiographs. Practice Intelligence\u00ae applies those same AI dental disease detection capabilities in conjunction with patient treatment data to uncover actionable insights and help streamline dental practices\u2019 clinical and operational performance. These solutions improve precision and diagnostic consistency across the dental field, significantly enhancing the patient care experience.\n<\/p>\n

\n\u201cThis recognition from Aragon Research further validates our efforts to fundamentally change dental diagnosis, treatment, clinical performance, and practice management,\u201d said Ophir Tanz<\/a>, founder and CEO of Pearl. \u201cOur advanced clinical AI solutions are helping dental practices around the world consistently deliver a higher standard of care, facilitating clearer communication with patients and promoting greater trust in providers.\u201d\n<\/p>\n

\nIn December, the Aragon Research Hot Vendors will be formally recognized at an award ceremony at Aragon Transform<\/a>. To learn more about the other vendors included, read the full Aragon Research report here.<\/a>\n<\/p>\n

\nAbout Pearl<\/b>\n<\/p>\n

\nPearl is shaping the future of dental care by delivering AI and computer vision solutions that advance efficiency, accuracy, transparency, and patient care. Founded in 2019 by Ophir Tanz, Pearl is backed by Craft Ventures and other leading venture capital firms. For more information or to request a demonstration, please visit https:\/\/www.hellopearl.com<\/a>.\n<\/p>\n

\nAragon Research Disclaimer<\/b>\n<\/p>\n

\nAragon Research does not endorse vendors, or their products or services that are referenced in its research publications and does not advise users to select those vendors that are rated the highest. Aragon Research publications consist of the opinions of Aragon Research and Advisory Services organization and should not be construed as statements of fact. Aragon Research provides its research publications and the information contained in them “AS IS,” without warranty of any kind.\n<\/p>\n

\ni<\/sup>Aragon Research \u201cHot Vendors\u201d in Computer Vision, 2022 by Adam Pease, August 4, 2022.\n<\/p>\n

\n\u00a9 2018 Aragon Research, Inc. and\/or its Affiliates. All Rights Reserved.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nHannah Fier
\n
Matter Health for Pearl
\n
Pearl@matternow.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Vendors selected for the report are noteworthy, visionary, and innovative in their respective fields LOS ANGELES–(BUSINESS WIRE)–Pearl, the global leader in dental AI solutions, announced today that it has been included on the 2022 list of “Hot Vendors” in Computer Visioni by Aragon Research, Inc. The firm\u2019s report identifies vendors whose technology provides transformative capabilities … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47263","6":"format-standard","7":"category-industry"},"yoast_head":"\nPearl Named 2022 "Hot Vendor" in Computer Vision by Aragon Research - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pearl Named 2022 "Hot Vendor" in Computer Vision by Aragon Research - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Vendors selected for the report are noteworthy, visionary, and innovative in their respective fields LOS ANGELES–(BUSINESS WIRE)–Pearl, the global leader in dental AI solutions, announced today that it has been included on the 2022 list of “Hot Vendors” in Computer Visioni by Aragon Research, Inc. The firm\u2019s report identifies vendors whose technology provides transformative capabilities ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-12T18:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220812005359\/en\/1543160\/21\/Pearl_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pearl Named 2022 “Hot Vendor” in Computer Vision by Aragon Research\",\"datePublished\":\"2022-08-12T18:02:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/\"},\"wordCount\":452,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220812005359\\\/en\\\/1543160\\\/21\\\/Pearl_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/\",\"name\":\"Pearl Named 2022 \\\"Hot Vendor\\\" in Computer Vision by Aragon Research - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220812005359\\\/en\\\/1543160\\\/21\\\/Pearl_logo.jpg\",\"datePublished\":\"2022-08-12T18:02:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220812005359\\\/en\\\/1543160\\\/21\\\/Pearl_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220812005359\\\/en\\\/1543160\\\/21\\\/Pearl_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pearl Named 2022 “Hot Vendor” in Computer Vision by Aragon Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pearl Named 2022 \"Hot Vendor\" in Computer Vision by Aragon Research - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/","og_locale":"en_US","og_type":"article","og_title":"Pearl Named 2022 \"Hot Vendor\" in Computer Vision by Aragon Research - Pharma Trend","og_description":"Vendors selected for the report are noteworthy, visionary, and innovative in their respective fields LOS ANGELES–(BUSINESS WIRE)–Pearl, the global leader in dental AI solutions, announced today that it has been included on the 2022 list of “Hot Vendors” in Computer Visioni by Aragon Research, Inc. The firm\u2019s report identifies vendors whose technology provides transformative capabilities ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-12T18:02:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220812005359\/en\/1543160\/21\/Pearl_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pearl Named 2022 “Hot Vendor” in Computer Vision by Aragon Research","datePublished":"2022-08-12T18:02:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/"},"wordCount":452,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220812005359\/en\/1543160\/21\/Pearl_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/","url":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/","name":"Pearl Named 2022 \"Hot Vendor\" in Computer Vision by Aragon Research - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220812005359\/en\/1543160\/21\/Pearl_logo.jpg","datePublished":"2022-08-12T18:02:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220812005359\/en\/1543160\/21\/Pearl_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220812005359\/en\/1543160\/21\/Pearl_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pearl-named-2022-hot-vendor-in-computer-vision-by-aragon-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pearl Named 2022 “Hot Vendor” in Computer Vision by Aragon Research"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47263"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47263\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47263"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47263"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}